Ketamine Hydrochloride Injection USP 10 mg (Ketamine (Ketamine Hydrochloride) SOLUTION) 10 MG

Ketamine Hydrochloride Injection USP 10 MG is a solution used for various medical purposes. This injectable form is manufactured by Sandoz Canada Incorporated and is commonly used in clinical settings.

Strength

10 MG

Pack Size

20 ML

Manufacturer / TM Owner

SANDOZ CANADA INCORPORATED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Ketamine Hydrochloride Injection is primarily used for anesthesia and pain management. It is often administered intramuscularly and is known for its rapid onset of action. This medication is also used in certain medical procedures where sedation is required. What is Ketamine Hydrochloride used for? It is typically used for inducing and maintaining anesthesia, as well as for managing pain in various clinical scenarios.

Side Effects

Common effects of Ketamine Hydrochloride Injection may include dissociation, dizziness, and changes in perception. Some individuals may experience hallucinations or altered states of consciousness. These effects are generally short-lived and subside as the medication wears off.

Precautions & Warnings

Ketamine Hydrochloride Injection should be handled with care and administered by healthcare professionals. It is important to follow proper storage guidelines and ensure the medication is used as directed. Patients with a history of certain medical conditions should consult their healthcare provider before use.

Avoid Interactions

Ketamine Hydrochloride Injection may interact with other medications, including alcohol and certain antidepressants. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always follow the advice of a healthcare professional regarding the use of this medication.

Frequently Asked Questions

Ketamine Hydrochloride Injection is primarily used for anesthesia and pain management in clinical settings.

This medication is typically administered intramuscularly by healthcare professionals.

Common effects may include dissociation, dizziness, and changes in perception.

It may interact with other medications, so it is important to consult a healthcare provider.

Ketamine Hydrochloride Injection is manufactured by Sandoz Canada Incorporated.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.